Score 2 CRVO (Penn State)

Completed Studies

Study of Comparative Treatments for Retinal Vein Occlusion 2 [Score 2]: a multi-center, prospective, randomized non-inferiority trial of eyes with macular edema secondary to central retinal vein occlusion, comparing intravitreal bevacizumab every 4 weeks with intravitreal aflibercept every 4 weeks.

Duration: 12 months

This entry was posted in Uncategorized. Bookmark the permalink.